BPMX

BioPharmX (BPMX)

BioPharmX Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:BPMX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/05/29	19 : 04	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	AMEX:BPMX	BioPharmX Corporation
2020/05/29	06 : 01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	AMEX:BPMX	BioPharmX Corporation
2020/05/28	06 : 23	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	AMEX:BPMX	BioPharmX Corporation
2020/05/23	06 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:BPMX	BioPharmX Corporation
2020/05/20	05 : 41	GlobeNewswire Inc.	Timber Pharmaceuticals Announces Investor Conference Call	AMEX:BPMX	BioPharmX Corporation
2020/05/16	05 : 36	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:BPMX	BioPharmX Corporation
2020/05/16	05 : 05	PR Newswire (US)	BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020	AMEX:BPMX	BioPharmX Corporation
2020/05/14	05 : 33	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:BPMX	BioPharmX Corporation
2020/05/14	05 : 31	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:BPMX	BioPharmX Corporation
2020/05/14	05 : 05	PR Newswire (US)	BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting	AMEX:BPMX	BioPharmX Corporation
2020/05/12	05 : 09	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:BPMX	BioPharmX Corporation
2020/05/12	05 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:BPMX	BioPharmX Corporation
2020/05/08	22 : 00	PR Newswire (US)	BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals	AMEX:BPMX	BioPharmX Corporation
2020/05/07	19 : 05	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:BPMX	BioPharmX Corporation
2020/04/28	05 : 20	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	AMEX:BPMX	BioPharmX Corporation
2020/04/28	05 : 13	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:BPMX	BioPharmX Corporation
2020/04/28	05 : 12	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:BPMX	BioPharmX Corporation
2020/04/28	05 : 05	PR Newswire (US)	BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 A...	AMEX:BPMX	BioPharmX Corporation
2020/04/07	05 : 55	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:BPMX	BioPharmX Corporation
2020/04/07	05 : 53	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:BPMX	BioPharmX Corporation
2020/04/07	05 : 30	PR Newswire (US)	Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials Grant	AMEX:BPMX	BioPharmX Corporation
2020/04/02	05 : 18	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	AMEX:BPMX	BioPharmX Corporation
2020/04/01	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:BPMX	BioPharmX Corporation
2020/03/31	05 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:BPMX	BioPharmX Corporation
2020/03/31	05 : 02	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:BPMX	BioPharmX Corporation
2020/03/30	19 : 17	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	AMEX:BPMX	BioPharmX Corporation
2020/03/26	05 : 15	PR Newswire (US)	BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain Trading	AMEX:BPMX	BioPharmX Corporation
2020/03/24	05 : 24	Edgar (US Regulatory)	Annual Report (10-k)	AMEX:BPMX	BioPharmX Corporation
2020/02/20	20 : 03	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	AMEX:BPMX	BioPharmX Corporation
2020/02/19	06 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:BPMX	BioPharmX Corporation